Overview

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy and safety on the use of rotigotine in patients suffering from Parkinson's Disease during and after surgery requiring general anaesthesia.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Treatments:
N 0437
Rotigotine